» Articles » PMID: 36158263

Crosstalk Between Dietary Patterns, Obesity and Nonalcoholic Fatty Liver Disease

Overview
Specialty Gastroenterology
Date 2022 Sep 26
PMID 36158263
Authors
Affiliations
Soon will be listed here.
Abstract

The prevalence of nonalcoholic fatty liver disease (NAFLD) is rising worldwide, paralleling the epidemic of obesity. The liver is a key organ for the metabolism of proteins, fats and carbohydrates. Various types of fats and carbohydrates in isocaloric diets differently influence fat accumulation in the liver parenchyma. Therefore, nutrition can manage hepatic and cardiometabolic complications of NAFLD. Even moderately reduced caloric intake, which leads to a weight loss of 5%-10% of initial body weight, is effective in improving liver steatosis and surrogate markers of liver disease status. Among dietary patterns, the Mediterranean diet mostly prevents the onset of NAFLD. Furthermore, this diet is also the most recommended for the treatment of NAFLD patients. However, clinical trials based on the dietary interventions in NAFLD patients are sparse. Since there are only a few studies examining dietary interventions in clinically advanced stages of NAFLD, such as active and fibrotic steatohepatitis, the optimal diet for patients in these stages of the disease must still be determined. In this narrative review, we aimed to critically summarize the associations between different dietary patterns, obesity and prevention/risk for NAFLD, to describe specific dietary interventions' impacts on liver steatosis in adults with NAFLD and to provide an updated overview of dietary recommendations that clinicians potentially need to apply in their daily practice.

Citing Articles

Carotenoids Improve Obesity and Fatty Liver Disease via Gut Microbiota: A Narrative Review.

Hashemi D, Fard M, Mohammadhasani K, Barati M, Nattagh-Eshtivani E Food Sci Nutr. 2025; 13(3):e70092.

PMID: 40071130 PMC: 11893484. DOI: 10.1002/fsn3.70092.


Canola Oil Ameliorates Obesity by Suppressing Lipogenesis and Reprogramming the Gut Microbiota in Mice via the AMPK Pathway.

Gao J, Ma L, Yin J, Li T, Yin Y, Chen Y Nutrients. 2024; 16(19).

PMID: 39408346 PMC: 11478415. DOI: 10.3390/nu16193379.


Polyphenol-rich black currant and cornelian cherry juices ameliorate metabolic syndrome induced by a high-fat high-fructose diet in rats.

Paunovic M, Milosevic M, Mitrovic-Ajtic O, Velickovic N, Micic B, Nedic O Heliyon. 2024; 10(7):e27709.

PMID: 38590904 PMC: 10999883. DOI: 10.1016/j.heliyon.2024.e27709.


The Effects of Olive Oil Consumption on Biochemical Parameters and Body Mass Index of People with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Tsamos G, Kalopitas G, Evripidou K, Vasdeki D, Koufakis T, Kanavas V Nutrients. 2024; 16(6).

PMID: 38542768 PMC: 10976078. DOI: 10.3390/nu16060857.


Analysis of the association between dietary patterns and nonalcoholic fatty liver disease in a county in Guangxi.

Xiao S, Chen Z, Mai T, Cai J, Chen Y, Tang X BMC Gastroenterol. 2023; 23(1):309.

PMID: 37704944 PMC: 10500788. DOI: 10.1186/s12876-023-02864-7.


References
1.
Tutunchi H, Saghafi-Asl M, Asghari-Jafarabadi M, Ostadrahimi A . Association between Dietary Patterns and Non-alcoholic Fatty Liver Disease: Results from a Case-Control Study. Arch Iran Med. 2021; 24(1):35-42. DOI: 10.34172/aim.2021.06. View

2.
Zhang S, Gu Y, Bian S, Lu Z, Zhang Q, Liu L . Soft drink consumption and risk of nonalcoholic fatty liver disease: results from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) cohort study. Am J Clin Nutr. 2021; 113(5):1265-1274. DOI: 10.1093/ajcn/nqaa380. View

3.
. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Clin Liver Dis (Hoboken). 2019; 11(4):81. PMC: 6385951. DOI: 10.1002/cld.722. View

4.
Entezari M, Talenezhad N, Mirzavandi F, Rahimpour S, Mozaffari-Khosravi H, Fallahzadeh H . Mediterranean dietary pattern and non-alcoholic fatty liver diseases: a case-control study. J Nutr Sci. 2021; 10:e55. PMC: 8327389. DOI: 10.1017/jns.2021.43. View

5.
Stanhope K, Schwarz J, Keim N, Griffen S, Bremer A, Graham J . Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009; 119(5):1322-34. PMC: 2673878. DOI: 10.1172/JCI37385. View